Variants of the FTO gene are associated with higher BMI and metabolic disturbances, factors that increase the risk of complications in pregnancy
Epitalon may not be a cancer drug, but it could be part of a future preventive protocol: a peptide that helps keep the cellular script clean before the chaos begins
SCFAs, especially butyrate, modulate the immune system by activating G-protein-coupled receptors (GPCRs), particularly G-protein-coupled receptor 43 (GPR43) and G-protein-coupled receptor 109A (GPR109A) (169)
The difference is that these medications have undergone years of research and large-scale clinical trials before receiving regulatory approval
Food and Drug Administration has not approved BPC-157 for medical treatment in humans
Peptides bind to specific receptors on cells, triggering biological responses that promote healing and restoration